Literature DB >> 10774994

2-ketoglutarate dehydrogenase deficiency with intermittent 2-ketoglutaric aciduria.

R J Dunckelmann1, F Ebinger, A Schulze, R J Wanders, D Rating, E Mayatepek.   

Abstract

2-ketoglutarate dehydrogenase (KGD) deficiency is a rare disorder of the tricarboxylic acid cycle. To date, 7 patients have been reported with clinical symptoms suggesting a neurodegenerative disease. We report a new patient in whom urinary excretion of 2-ketoglutaric acid (KGA) was intermittently found to be within normal ranges. At birth, the male patient suffered from mild perinatal asphyxia due to meconium aspiration. During the first months of life, he developed an opisthotonus, hyperexcitability and truncal hypertonia. At the present age of 14 months, these neurological symptoms became less pronounced. A cranial MRI was normal. Urinary 2-KGA excretion was found to be intermittently increased in 3 of 6 analyses between 2 weeks and 14 months of age (5-1700 mmol/mol creatinine, controls: < 340 mmol/mol creatinine). 2-KGA was not increased in plasma and CSF. Diagnosis was confirmed by measurement of decreased 2-KGD activity in cultured skin fibroblasts. This report demonstrates that the diagnosis of 2-KGD deficiency can easily be missed. In case of doubt, 2-KGD activity should be measured in fibroblasts. The clinical and long-term outcome of patients with 2-KGD deficiency is unknown. Further reports and long-term evaluation are required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774994     DOI: 10.1055/s-2000-15295

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

1.  Absence of Nails, Deaf-mutism, Seizures, and Intellectual Disability: A Case Report.

Authors:  Lal Devayanivasudevan Nair; Benjamin Sagayaraj; Radha Kumar
Journal:  J Clin Diagn Res       Date:  2015-04-01

2.  Behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases.

Authors:  L Trofimova; M Lovat; A Groznaya; E Efimova; T Dunaeva; M Maslova; A Graf; V Bunik
Journal:  Int J Alzheimers Dis       Date:  2010-10-26

3.  A biallelic pathogenic variant in the OGDH gene results in a neurological disorder with features of a mitochondrial disease.

Authors:  Zheng Yie Yap; Klaudia Strucinska; Satoshi Matsuzaki; Sukyeong Lee; Yue Si; Kenneth Humphries; Mark A Tarnopolsky; Wan Hee Yoon
Journal:  J Inherit Metab Dis       Date:  2020-06-24       Impact factor: 4.982

4.  Frequent detection of parental consanguinity in children with developmental disorders by a combined CGH and SNP microarray.

Authors:  Yao-Shan Fan; Xiaomei Ouyang; Jinghong Peng; Stephanie Sacharow; Mustafa Tekin; Deborah Barbouth; Olaf Bodamer; Roman Yusupov; Christina Navarrete; Ana H Heller; Sérgio Dj Pena
Journal:  Mol Cytogenet       Date:  2013-09-20       Impact factor: 2.009

5.  α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.

Authors:  Sandra Atlante; Alessia Visintin; Elisabetta Marini; Matteo Savoia; Chiara Dianzani; Marta Giorgis; Duran Sürün; Federica Maione; Frank Schnütgen; Antonella Farsetti; Andreas M Zeiher; Massimo Bertinaria; Enrico Giraudo; Francesco Spallotta; Chiara Cencioni; Carlo Gaetano
Journal:  Cell Death Dis       Date:  2018-07-09       Impact factor: 8.469

6.  OGDH is involved in sepsis induced acute lung injury through the MAPK pathway.

Authors:  Yuewei Hao; Zheng Wang; Xinfang Wang; Wenming Zhan; Dianshui Wu
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

Review 7.  Pediatric thiamine deficiency disorders in high-income countries between 2000 and 2020: a clinical reappraisal.

Authors:  Benjamin Rakotoambinina; Laurent Hiffler; Filomena Gomes
Journal:  Ann N Y Acad Sci       Date:  2021-07-26       Impact factor: 6.499

8.  Dual mode action of mangiferin in mouse liver under high fat diet.

Authors:  Jihyeon Lim; Zhongbo Liu; Pasha Apontes; Daorong Feng; Jeffrey E Pessin; Anthony A Sauve; Ruth H Angeletti; Yuling Chi
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.